Document Detail


Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study.
MedLine Citation:
PMID:  18436917     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls.
DESIGN: Prospective cohort study.
SETTING: 36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom.
PARTICIPANTS: 2817 schoolgirls in year 8 (12 and 13 year olds).
INTERVENTION: Delivery of the bivalent vaccine at 0, 1, and 6 months over one school year.
MAIN OUTCOME MEASURES: Vaccine uptake for doses 1 and 2 of a three dose schedule.
RESULTS: Vaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second dose. Uptake was significantly lower in schools with a higher proportion of ethnic minority girls (P<0.001 for trend) or higher proportion of girls entitled to free school meals (P=0.029 for trend). The main reason for parents' refusal of vaccination was insufficient information about the vaccine and its long term safety. Maintaining the vaccine schedule was challenging as 16.3% (dose 1) and 23.6% (dose 2) of girls missed their vaccination day and had to be offered alternative appointments. No serious adverse events were reported.
CONCLUSION: Delivery of the first two doses of HPV vaccine to adolescent schoolgirls is encouraging, but the success of the vaccination programme depends on high coverage for the third dose.
Authors:
Loretta Brabin; Stephen A Roberts; Rebecca Stretch; David Baxter; Gloria Chambers; Henry Kitchener; Rosemary McCann
Related Documents :
8879097 - Interference assessment of yellow fever vaccine with the immune response to a single-do...
9849987 - Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactiva...
16822597 - A comparison of booster immunisation with a combination dtpa-ipv vaccine or dtpa plus i...
3020057 - The antibody response of seronegative infants to inactivated poliovirus vaccine of enha...
15474717 - Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis com...
15841577 - Evolution of anti-influenza vaccination coverage in spain from 1993 to 2001.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-04-24
Journal Detail:
Title:  BMJ (Clinical research ed.)     Volume:  336     ISSN:  1756-1833     ISO Abbreviation:  BMJ     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-05-09     Completed Date:  2008-05-28     Revised Date:  2012-03-06    
Medline Journal Info:
Nlm Unique ID:  8900488     Medline TA:  BMJ     Country:  England    
Other Details:
Languages:  eng     Pagination:  1056-8     Citation Subset:  AIM; IM    
Affiliation:
Academic Unit of Obstetrics and Gynaecology, St Mary's Hospital, University of Manchester, Manchester M13 OJH. loretta.brabin@manchester.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Cohort Studies
Delivery of Health Care
England
Female
Humans
Papillomavirus Infections / prevention & control*
Papillomavirus Vaccines / administration & dosage*
Patient Acceptance of Health Care / statistics & numerical data*
Prospective Studies
School Health Services
Vaccination / utilization
Chemical
Reg. No./Substance:
0/Papillomavirus Vaccines
Comments/Corrections
Comment In:
BMJ. 2008 May 24;336(7654):1146   [PMID:  18497380 ]
BMJ. 2008 May 10;336(7652):1028-9   [PMID:  18436916 ]
BMJ. 2008 May 24;336(7654):1146   [PMID:  18497381 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
Next Document:  Inequity of access to investigation and effect on clinical outcomes: prognostic study of coronary an...